Handelsbanken Fonder
BEAM icon

Handelsbanken Fonder’s Beam Therapeutics BEAM Stock Holding History

Handelsbanken Fonder’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
39,823
+6,200
+18% +$187K ﹤0.01% 988
2026
Q1 		$801K Hold
33,623
– – ﹤0.01% 1138
2025
Q4 		$932K Sell
33,623
-17,500
-34% -$446K ﹤0.01% 1061
2025
Q3 		$1.24M Buy
51,123
+22,223
+77% +$442K ﹤0.01% 921
2025
Q2 		$492K Buy
28,900
+1,400
+5% +$24.4K ﹤0.01% 1257
2025
Q1 		$537K Hold
27,500
– – ﹤0.01% 1211
2024
Q4 		$682K Sell
27,500
-1,000
-4% -$25.5K ﹤0.01% 1165
2024
Q3 		$698K Buy
28,500
+10,900
+62% +$282K ﹤0.01% 1096
2024
Q2 		$412K Buy
17,600
+700
+4% +$17.2K ﹤0.01% 1241
2024
Q1 		$558K Hold
16,900
– – ﹤0.01% 1114
2023
Q4 		$460K Buy
16,900
+6,400
+61% +$159K ﹤0.01% 1192
2023
Q3 		$253K Hold
10,500
– – ﹤0.01% 1371
2023
Q2 		$335K Buy
10,500
+1,100
+12% +$35.7K ﹤0.01% 1292
2023
Q1 		$288K Hold
9,400
– – ﹤0.01% 1312
2022
Q4 		$368K Buy
9,400
+5,000
+114% +$224K ﹤0.01% 1135
2022
Q3 		$210K Buy
+4,400
New +$251K ﹤0.01% 1419
2022
Q2 		– Sell
-8,900
Closed -$510K – 1621
2022
Q1 		$510K Hold
8,900
– – ﹤0.01% 1196
2021
Q4 		$709K Buy
8,900
+700
+9% +$59.9K ﹤0.01% 1109
2021
Q3 		$713K Hold
8,200
– – ﹤0.01% 1109
2021
Q2 		$1.05M Buy
8,200
+1,500
+22% +$120K 0.01% 889
2021
Q1 		$536K Hold
6,700
– – ﹤0.01% 1161
2020
Q4 		$547K Buy
+6,700
New +$329K ﹤0.01% 1112

Other funds holding BEAM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $2.17B AUM 134.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Handelsbanken Fonder's BEAM Position: Q2 2026 in Review

Handelsbanken Fonder increased its Beam Therapeutics (BEAM) stake by 18% in Q2 2026, buying an estimated $187K and bringing the position to 39,823 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #988.

Handelsbanken Fonder first reported a position in BEAM in Q4 2020 and has held it in 22 quarters since. 162 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Handelsbanken Fonder held 39,823 shares of Beam Therapeutics worth $1.37M as of Q2 2026.
  • Handelsbanken Fonder bought 6,200 Beam Therapeutics shares in Q2 2026, an estimated $187K.
  • Beam Therapeutics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #988 holding.
  • Handelsbanken Fonder first reported a position in Beam Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • 162 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.